1. Кукес В.Г., Остроумова О.Д. Кардиомагнил. Новый взгляд на ацетилсалициловую кислоту. Пособие для врачей. 2004.
2. Остроумова О.Д. Возможности применения кардиомагнила у пациентов с сахарным диабетом. Рус. мед. журн. 2004; 12 (5): 350–4.
3. Cole FT, Hudson N, Liew LC et al. Protection of Human gastric mucosa against aspirin-enteric coating or dose reduction? Aliment Pharmacol Ther 1999; 13 (2): 187–93.
4. Dommann HG, Burhardt F, Wolf N. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Aliment Pharmacol Ther 1999; 13 (8): 1109–14.
5. Kelly JP, Kaufman DW, Jugelon JM et al. Risk of aspirin-associated major upper- gastrointestinal bleeding with enteric-coated or buffered product. Luncet 1996; 348: 1413–7.
6. Petrosky D. Gastric safety and enteric-coated aspirin. Luncet 1997; 349–54.
7. Savon J, Allen ML, DiMarino AJ. Gastrointestinal blood loss with low-dose (325 mg) plain and enteric-coated aspirin administration. Am J Gastrointerol 1995; 90: 581–6.